Delbruk Pharmaceuticals Private Limited
About Delbruk Pharmaceuticals Private Limited
Data last updated:
Delbruk Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 20 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2023PTC410253.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramanuj Mukherjee and Bhumika.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 60 Ground Floor Pocket C – 5 Sector 11 Rohini, Delhi, India – 110085.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Delbruk Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered Address60 Ground Floor Pocket C – 5 Sector 11 Rohini, Delhi, India – 110085
- IndustryHealthcare, Manufacturing, Other Medical And Surgical Equipment, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Delbruk Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Delbruk Pharmaceuticals Private Limited, buy the company report.
Board of directors of Delbruk Pharmaceuticals Private Limited
Delbruk Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramanuj Mukherjee Also directs: Delbruk Lifescience Private Limited | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
| Bhumika Also directs: Delbruk Lifescience Private Limited | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Delbruk Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Delbruk Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Delbruk Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Delbruk Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Bhumika was appointed as Director on 20 Jan 2023.
Frequently asked questions
Delbruk Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 20 January 2023 (3+ years old) and is registered under CIN U33119DL2023PTC410253.
Delbruk Pharmaceuticals has 2 current directors:
- Ramanuj Mukherjee - Director
- Bhumika - Director
The latest financial statements of Delbruk Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Delbruk Pharmaceuticals is U33119DL2023PTC410253. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delbruk Pharmaceuticals was incorporated on 20 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Bhumika was appointed as Director on 20 Jan 2023. Ramanuj Mukherjee was appointed as Director on 20 Jan 2023.
The registered office of Delbruk Pharmaceuticals is at 60 Ground Floor Pocket C – 5 Sector 11 Rohini, Delhi, India – 110085.
Delbruk Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.
The compliance status of Delbruk Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.
Delbruk Pharmaceuticals can be reached at its registered office: 60 Ground Floor Pocket C – 5 Sector 11 Rohini, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
